Smartleaf Asset Management’s RxSight RXST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-15
Closed -$162 3627
2025
Q4
$162 Buy
+15
New +$151 ﹤0.01% 3378
2025
Q2
Sell
-17
Closed -$451 2938
2025
Q1
$451 Buy
17
+7
+70% +$208 ﹤0.01% 2713
2024
Q4
$338 Sell
10
-35
-78% -$1.58K ﹤0.01% 2829
2024
Q3
$2.18K Buy
45
+18
+67% +$922 ﹤0.01% 2443
2024
Q2
$1.59K Buy
+27
New +$1.54K ﹤0.01% 2303

Other funds holding RXST

Smartleaf Asset Management's RXST Position: Q1 2026 in Review

Smartleaf Asset Management sold out of RxSight (RXST) in Q1 2026, closing a stake of 15 shares — an estimated $162 sold.

Smartleaf Asset Management first reported a position in RXST in Q2 2024 and held it in 5 quarters. The position peaked at $2.18K in Q3 2024. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.

  • Smartleaf Asset Management reported no remaining RxSight position as of Q1 2026 after selling out during the quarter.
  • Smartleaf Asset Management sold 15 RxSight shares in Q1 2026, an estimated $162.
  • Smartleaf Asset Management first reported a position in RxSight in Q2 2024 and held it in 5 quarters.
  • Smartleaf Asset Management's RxSight position peaked at $2.18K in Q3 2024.
  • 164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.

Based on Smartleaf Asset Management's 13F filing for Q1 2026, filed 15 May 2026.